Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessment.
Ying-Chieh LaiWen-Cheng ChangChun-Bing ChenChi-Liang WangYu-Fen LinMing-Mo HoChi-Yuan ChengPei-Wei HuangChao-Wei HsuGigin LinPublished in: Acta radiologica (Stockholm, Sweden : 1987) (2019)
Pseudoprogression in immunotherapy may be captured through semi-automatic software utilizing irRC or iRECIST criteria. iRECIST-based response evaluation may provide a better survival stratification compared with subjective assessment.